OpenAlex
PricingAboutJobs
Log inGet started
Work

Niraparib: First Global Approval

HTML

Year: 2017
Type: article
Source: Drugs
DOI: 10.1007/s40265-017-0752-y
Author: Lesley J. Scott
Institution: Springer Nature (New Zealand)
Language: English

Topic: PARP inhibition in cancer therapy
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: niraparib, PARP inhibitors, PARP1, PARP2, maintenance therapy, recurrent epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer, platinum-sensitive ovarian cancer, progression-free survival, germline BRCA mutation, homologous recombination deficiency, drug approval, breast cancer, prostate cancer
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2611848593
FWCI: 8.639
Cites: 15
Cited by: 200
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms